Articles in Scholarly Journals [Incomplete List]

1. 1,25 dihydroxyvitamin-D3 modulates JAK–STAT pathway in IL-12/IFN? axis leading to Th1 response in experimental allergic encephalomyelitis
   Journal of Neuroscience Research, vol. 83, no. 7, pp. 1299–1309, 2006
2. COX-2 Inhibitors Modulate IL-12 Signaling Through JAK-STAT Pathway Leading to Th1 Response in Experimental Allergic Encephalomyelitis
   Journal of Clinical Immunology, vol. 26, no. 1, pp. 73–85, 2006
3. Curcumin induces growth-arrest and apoptosis in association with the inhibition of constitutively active JAK–STAT pathway in T cell leukemia
   Biochemical and Biophysical Research Communications, vol. 340, no. 2, pp. 359–368, 2006
4. Setaria digitata secreted filarial lipids modulate IL-12 signaling through JAK-STAT pathway leading to the development of Th1 response
   Experimental Parasitology, vol. 114, no. 3, pp. 193–203, 2006
5. PPAR? antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-Deoxy-?12,14-Prostaglandin J2
   Journal of Neuroimmunology, vol. 178, no. 1-2, pp. 76–86, 2006
6. 15-Deoxy-?12,14-Prostaglandin J2 regulates leukemia inhibitory factor signaling through JAK-STAT pathway in mouse embryonic stem cells
   Experimental Cell Research, 2006
7. PPAR? antagonists exacerbate neural antigen-specific Th1 response and experimental allergic encephalomyelitis
   Journal of Neuroimmunology, vol. 167, no. 1-2, pp. 99–107, 2005
8. Signaling through JAK2-STAT5 pathway is essential for IL-3-induced activation of microglia
   Glia, vol. 45, no. 2, pp. 188–196, 2004
9. Erratum
   Glia, vol. 47, no. 4, pp. 387–388, 2004
10. Targeting autoimmune diseases through nutraceuticals
    Nutrition, vol. 20, no. 1, pp. 39–43, 2004
11. Quercetin, a Flavonoid Phytoestrogen, Ameliorates Experimental Allergic Encephalomyelitis by Blocking IL-12 Signaling Through JAK-STAT Pathway in T Lymphocyte
    Journal of Clinical Immunology, vol. 24, no. 5, pp. 542–552, 2004
12. Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation
    Genes and Immunity, vol. 3, no. 2, Article ID 6363832, 11 pages, 2002
13. Immunotherapy of Inflammatory Demyelinating Diseases of the Central Nervous System
    Immunologic Research, vol. 23, no. 2-3, pp. 245–252, 2001
14. Inhibition of CD40 signaling pathway by tyrphostin A1 reduces secretion of IL-12 in macrophage, Th1 cell development and experimental allergic encephalomyelitis in SJL/J mice
    Journal of Neuroimmunology, vol. 114, no. 1-2, pp. 69–79, 2001
15. Expression of IL-12 in CNS and lymphoid organs of mice with experimental allergic encephalitis
    Journal of Neuroimmunology, vol. 82, no. 1, pp. 22–30, 1998
16. Successful treatment of established relapsing experimental autoimmune encephalomyelitis in mice with a monoclonal natural autoantibody
    Journal of Neuroimmunology, vol. 75, no. 1-2, pp. 204–209, 1997
17. Vaccination with peptides from MHC class II beta chain hypervariable region causes allele-specific suppression of EAE
    Journal of Neuroimmunology, vol. 67, no. 2, pp. 119–124, 1996
18. AK-5 Tumor-Induced Expression of Interleukin-12: Role of IL-12 in NK-Mediated AK-5 Regression
    Cellular Immunology, vol. 162, no. 2, pp. 241–247, 1995
19. Decreased CD3-mediated interferon-? production in relapsing-remitting multiple sclerosis
    Annals of Neurology, vol. 37, no. 4, pp. 546–549, 1995